Salmedix's Unattributed VC - IV Round

Salmedix raised a round of funding on March 24, 2004.

Salmedix was a start-up biotechnology firm focused on discovering and developing minimally-toxic therapies to treat cancers, particularly those that affect the growing global geriatric population.…

Articles about Salmedix's Unattributed VC - IV Round: